Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin; medicine for internal use, such as digestive and herbal medicines; oral medicines comprising gastrointestinal medicines, herbal medicines, and supplements; non-prescription medicines; and beauty counters that provide beauty and health services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. Rohto Pharmaceutical Co.,Ltd. was founded in 1899 and is headquartered in Osaka, Japan.
P/B ratio for Rohto Pharmaceutical Co.,Ltd. (4527.T)
P/B ratio as of 2023: 2.78
According to Rohto Pharmaceutical Co.,Ltd.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.78. At the end of 2022 the company had a P/B ratio of 3.02.
P/B ratio history for Rohto Pharmaceutical Co.,Ltd. from 2007 to 2023
P/B ratio at the end of each year
| Year | P/B ratio |
|---|---|
| 2023 | 2.78 |
| 2022 | 3.02 |
| 2021 | 2.36 |
| 2020 | 2.16 |
| 2019 | 2.42 |
| 2018 | 2.48 |
| 2017 | 2.65 |
| 2016 | 2.01 |
| 2015 | 2.10 |
| 2014 | 1.76 |
| 2013 | 2.14 |
| 2012 | 1.54 |
| 2011 | 1.44 |
| 2010 | 1.32 |
| 2009 | 1.62 |
| 2008 | 1.55 |
| 2007 | 2.06 |